Earum Pharmaceuticals Ltd.
| BSE: 542724 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE060601023 |
| BSE 00:00 | 04 Jul | 3.28 |
0.07 (2.18%) |
OPEN
3.16 |
HIGH
3.29 |
LOW
3.08 |
| NSE 05:30 | 01 Jan | Earum Pharmaceuticals Ltd |
| OPEN | 3.16 |
| PREVIOUS CLOSE | 3.21 |
| VOLUME | 353978 |
| 52-Week high | 26.40 |
| 52-Week low | 3.08 |
| P/E | 9.11 |
| Mkt Cap.(Rs cr) | 20 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Earum Pharmaceuticals Ltd. (EARUMPHARMACEU) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 828.70 | 0.24 | 966.90 | 664.10 | 198829.98 |
| Divi's Lab. | 3638.40 | 0.10 | 5425.00 | 3365.10 | 96581.33 |
| Cipla | 930.35 | -2.08 | 1083.15 | 850.00 | 75069.94 |
| Dr Reddy's Labs | 4365.70 | -0.43 | 5613.65 | 3655.00 | 72662.71 |
| Apollo Hospitals | 3772.55 | 1.00 | 5930.70 | 3365.90 | 54241.72 |
| Torrent Pharma. | 2904.85 | -0.35 | 3304.45 | 2485.00 | 49155.87 |
| Gland Pharma | 2592.55 | -2.39 | 4350.00 | 2498.00 | 42699.30 |
| Abbott India | 18940.10 | -0.74 | 23902.30 | 15525.00 | 40247.71 |
| Piramal Enterp. | 1681.05 | 0.64 | 3013.00 | 1561.00 | 40118.26 |
| Biocon | 311.20 | -0.14 | 414.30 | 305.00 | 37362.67 |
| Zydus Lifesci. | 360.05 | -0.57 | 651.75 | 319.40 | 36858.32 |
| Alkem Lab | 3040.35 | 0.67 | 4067.70 | 2835.00 | 36347.38 |
| Max Healthcare | 365.75 | 1.70 | 472.60 | 257.05 | 35464.22 |
| Aurobindo Pharma | 528.65 | 1.17 | 1008.75 | 503.40 | 30973.60 |
| Lupin | 628.75 | 0.03 | 1193.00 | 583.05 | 28582.97 |
| Glaxosmi. Pharma | 1531.65 | 1.88 | 1917.00 | 1433.05 | 25947.68 |
| Laurus Labs | 468.90 | 0.57 | 723.55 | 433.20 | 25196.34 |
| Ipca Labs. | 918.30 | 0.59 | 1383.55 | 831.40 | 23297.27 |
| Syngene Intl. | 556.65 | -0.78 | 699.95 | 508.10 | 22345.60 |
| Pfizer | 4103.95 | -0.21 | 6164.80 | 4056.00 | 18775.57 |
Quick Links for Earum Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
